| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 05/19/2004 | DE10250297A1 Kristalle von Insulinanaloga und Verfahren zu ihrer Herstellung Crystals of insulin analogs and methods for their preparation |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1498226A Thrombin derivatives and its process for production, anhydrothrombin derivatives and its production method, platelet agglutination-inducing compositions, method of inducing platelet agglutination,... |
| 05/19/2004 | CN1498225A Template-fixed peptidomimetics with antimicrobial activity |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1498223A Anti-angiogenic polyeptides |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498113A Insulin preparations, which donot contain any zinc or only small quantity of zinc of improved stability |
| 05/19/2004 | CN1498112A Combination therapy for estrogen-dependent disorders |
| 05/19/2004 | CN1498111A Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof |
| 05/19/2004 | CN1498107A Combination of taxane and cyclin-dependent kinase inhibitor |
| 05/19/2004 | CN1498105A Synergistic combinations of vitaminosis A receptor ligands and selected cytotoxic agents for treatment of cancer |
| 05/19/2004 | CN1498103A Novel use of peptide class of compound for treating non-neuropathic inflammatory pain |
| 05/19/2004 | CN1498083A Health foods containing natto kinase and fermented milk products |
| 05/19/2004 | CN1498079A Use of food and drink as delevery system for phytase in humans |
| 05/19/2004 | CN1497049A Androgen receptor compound-associated protein |
| 05/19/2004 | CN1497046A Alpha ketonic acid reductase and its preparation method, and method of preparing optical active alpha hydroxy acid using said reductase |
| 05/19/2004 | CN1496743A Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496732A Oil-in-water oxidation paste emulsion for treating human kexatin fiber |
| 05/19/2004 | CN1150327C Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method |
| 05/19/2004 | CN1150319C Identification of human cell lines for prodn. of human proteins by endogenous gene activation |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/19/2004 | CN1150317C Gene associated with esophagus cancer |
| 05/19/2004 | CN1150208C Thymosin aplpha-1 derivatives |
| 05/19/2004 | CN1150207C Gclq receptor, HIV-1 ph120 region binding thereto, and related peptides and targeting antibodies |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150032C Concentrated granular medicine for treating baby diarrhea and its preparing process |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150029C Methods for administration of antibiotics |
| 05/19/2004 | CN1150028C Tri-, tetra-, penta- and polypeptides and their therapeuitc use as antidepressant agent |
| 05/19/2004 | CN1150004C Low temperature albumin fractionation using sodium caprylates as partitioning agent |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149975C Compositions containing a peptide and polylactic-glycolic acid subitable for preparing subcutaneous implants with and extended release period |
| 05/19/2004 | CN1149967C Site-specitic preparation of polyethylene glycol-GRF conjujates |
| 05/19/2004 | CA2449540A1 Method of treating left ventricular dysfunction |
| 05/18/2004 | US6737523 For treatment of various forms of cancer |
| 05/18/2004 | US6737522 Chicken interleukin-15 and uses thereof |
| 05/18/2004 | US6737521 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 05/18/2004 | US6737515 Follicle stimulating hormone-glycosylation analogs |
| 05/18/2004 | US6737514 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/18/2004 | US6737512 Enzymatic polypeptide for use in the treatment of infections |
| 05/18/2004 | US6737511 With two domains that target cell and modify apoptotic response |
| 05/18/2004 | US6737509 For treating diabetes using insulin homolog polypeptide |
| 05/18/2004 | US6737508 DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737506 For modulating oxidative damage to intracellular components such as mitochondrial dna (mtdna) and mitochondrial protein |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737414 Composition for enteral nutrition comprising fibres |
| 05/18/2004 | US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/18/2004 | US6737412 Antisense oligodeoxynucleotides regulating expression of TNF α |
| 05/18/2004 | US6737409 For cancer therapy |
| 05/18/2004 | US6737408 Dipeptide and tripeptide derivatives |
| 05/18/2004 | US6737407 Treatment of obesity |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737405 Mixing with polysaccharide and amino acid |
| 05/18/2004 | US6737404 Wound healing agents, antiulcer agents, vision defects |
| 05/18/2004 | US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide |
| 05/18/2004 | US6737402 Supercharged zinc fetuin; incubating fetuin with a chelating agent, especially edta; isolating naked fetuin; incubating the naked fetuin with zinc acetate |
| 05/18/2004 | US6737399 Using histacalin protein isolated from ticks |
| 05/18/2004 | US6737398 Administering tumor necrosis factor-alpha directly to lung tissue |
| 05/18/2004 | US6737397 Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737259 Modified with polyethylene glycol for treatment and inhibition of cancer and metastasis |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737250 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737233 Method for preparing HCV E2 binding protein |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737079 For burns, injuries of skin; lyases enzyme on carrier |
| 05/18/2004 | US6737076 Hypoallergenic composition containing tolerogenic peptides |
| 05/18/2004 | US6737075 Using enzyme for the manufacture of a medicament to eliminate corneal scar, opacity, and haze |
| 05/18/2004 | US6737074 Cells in a culture medium bind to fibrin microbeads which are biologically active and comprise very crosslinked fibrin(ogen); transplanting; engineering tissue by applying to a prosthesis; separating cells; wound healing agents |
| 05/18/2004 | US6737072 Matrix for tissue engineering formed of a hyaluronic acid ester and hydrolyzed collagen |
| 05/18/2004 | US6737064 Antitumor agents |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis |
| 05/18/2004 | US6737058 Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodies |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737055 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith |
| 05/18/2004 | US6737052 Induction of programmed cell death by N5 gene |
| 05/18/2004 | US6737045 Methods and compositions for the pulmonary delivery insulin |
| 05/18/2004 | US6737044 Aerosol composition |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/13/2004 | WO2004040298A2 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment |
| 05/13/2004 | WO2004040262A2 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | WO2004040009A2 Protozoan rhomboid proteins |
| 05/13/2004 | WO2004040000A2 G protein coupled receptors and uses thereof |
| 05/13/2004 | WO2004039999A2 Essential dna enclosed proteins of drosphophilia melanogaster |
| 05/13/2004 | WO2004039974A1 Novel protein and dna thereof |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039961A2 Trefoil domain-containing polypeptides and uses thereof |
| 05/13/2004 | WO2004039958A2 Lutzomyia longipalpis polypeptides and methods of use |